Key Protein May Lead to Novel IBD Therapies for Colon Inflammation, Crohn’s, Ulcerative Colitis

Key Protein May Lead to Novel IBD Therapies for Colon Inflammation, Crohn’s, Ulcerative Colitis
Researchers identified a novel cellular mechanism responsible for increasing inflammation in the colon (large intestine), a common feature triggering Crohn’s disease, ulcerative colitis, even colon cancer. The study, “Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination,” was recently published in the journal Nature Immunology, and identified novel players for future targeted therapeutics in inflammatory bowel diseases (IBDs) and colon cancer. Researchers at Baylor Institute for Immunology
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *